Taro Shareholder Value Creation and Strategic Overview
5
or
Company Overview
Key Dates in Taro History
1950 - Established in Israel to manufacture finished pharmaceutical products
1961 - Started chemical synthesis (API production) in Israel
TARO
1984 - Established
d topical product operations in Canada
1988 - Entered U.S. market
TARO
TARO
LISTED
NYSE
2010 Sun Pharma acquires controlling interest in Taro
2012 NYSE Listed
2019 Exited branded presence in U.S.
-
2022 Alchemee Acquisition
-
2023 - Sun Pharma announces proposal to acquire all of Taro's outstanding ordinary shares
Share Repurchases:
☐
2013 – $193M (Dutch Tender): 2.0M shares
2016/2017 - $500M (10b5-1): 4.3M shares
2019 - $300M announced:
2019 – $25M (Dutch Tender): 281K shares
▪2021 - $50M (10b5-1): 673K shares
Special Dividend:
2018 $500M: $12.86 per share
TARO
LISTED
NYSE
TAROView entire presentation